BioCentury
ARTICLE | Company News

4SC, Immunic deal

October 3, 2016 7:00 AM UTC

Immunic acquired 4SC’s immunology portfolio, including preclinical programs IMU-366 and IMU-838. 4SC will receive an undisclosed upfront payment and is eligible for milestones and royalties. Immunic w...